A comparison of psychosocial and cognitive functioning between depressed and non-depressed patients with cannabis dependence.

Journal of Addictive Diseases
Alex M SecoraFrances R Levin

Abstract

Cannabis use and depressive disorders are thought to impair cognitive performance and psychosocial functioning. Both disorders co-occurring may compound the negative effects of these diagnoses. In this study, the authors used the California Computerized Assessment Package as the cognitive performance measure and the Addiction Severity Index as the psychosocial functioning measure to compare individuals who were cannabis dependent and either depressed or not depressed (N= 108: 54 cannabis dependent only, 54 cannabis dependent and depressed or dysthymic). As predicted, cannabis dependent individuals with comorbid depression showed more psychosocial impairment than individuals with cannabis dependence alone. However, contrary to the authors' hypothesis, individuals who were cannabis dependent with comorbid depression showed less cognitive impairment in some California Computerized Assessment Package modules than individuals with cannabis dependence alone. Based on the authors' results, they concluded that the additive effects of cannabis dependency and depression may only be limited to psychosocial domains and may not extend to cognitive functioning.

References

Jul 1, 1977·The British Journal of Psychiatry : the Journal of Mental Science·J W KnesevichV E Ziegler
Jan 1, 1992·Journal of Substance Abuse Treatment·A T McLellanM Argeriou
Mar 1, 1992·The Journal of Nervous and Mental Disease·D C Hodgins, N el-Guebaly
Jun 1, 1992·The Journal of Applied Psychology·W E Lehman, D D Simpson
May 1, 1992·Journal of Affective Disorders·M P AustinG M Goodwin
Apr 1, 1983·Journal of Consulting and Clinical Psychology·M W O'Hara, L P Rehm
Feb 21, 1996·JAMA : the Journal of the American Medical Association·H G Pope, D Yurgelun-Todd
Mar 1, 1996·The Psychiatric Clinics of North America·D N KleinM B Keller
Jan 1, 1996·Depression·A J GruberM E Brown
Nov 13, 1998·The American Journal of Psychiatry·J WestermeyerS Nugent
Dec 16, 1998·The American Journal of Drug and Alcohol Abuse·S L EamesR D Crosby
Feb 24, 2001·The Australian and New Zealand Journal of Psychiatry·W Hall, L Degenhardt
Mar 21, 2001·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·S F ButlerJ S Cacciola
Sep 21, 2001·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·G B BovassoT G Cook
Nov 1, 2001·Archives of General Psychiatry·H G PopeD Yurgelun-Todd
Nov 15, 2001·Current Psychiatry Reports·H G PopeD Yurgelun-Todd
Dec 1, 2001·The American Journal of Psychiatry·G B Bovasso
Mar 7, 2002·JAMA : the Journal of the American Medical Association·Nadia SolowijUNKNOWN Marijuana Treatment Project Research Group
Nov 5, 2002·Journal of Clinical Pharmacology·Harrison G PopeDeborah Yurgelun-Todd
Feb 28, 2003·Journal of Clinical and Experimental Neuropsychology·Jens EgelandKirsten I Stordal
Mar 4, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Richard J PorterAllan H Young
Jun 19, 2003·JAMA : the Journal of the American Medical Association·Ronald C KesslerUNKNOWN National Comorbidity Survey Replication
Jun 24, 2003·Depression and Anxiety·Thomas EllwartEni S Becker
Aug 15, 2003·The Cochrane Database of Systematic Reviews·M Silva de Lima, M Hotopf
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Nov 18, 2003·Addiction·Louisa DegenhardtMichael Lynskey
Dec 16, 2003·Psychological Medicine·A J GruberD Yurgelun-Todd
Mar 31, 2004·Social Psychiatry and Psychiatric Epidemiology·Mikkel Arendt, Povl Munk-Jørgensen
Apr 22, 2004·JAMA : the Journal of the American Medical Association·Edward V Nunes, Frances R Levin
May 6, 2004·JAMA : the Journal of the American Medical Association·Wilson M ComptonFrederick S Stinson
Nov 5, 2004·Comprehensive Psychiatry·David A SolomonMartin B Keller
Mar 1, 2005·Neurotoxicology and Teratology·P A FriedR Gray
Oct 6, 2005·Drug and Alcohol Review·W Hall
Dec 6, 2005·Journal of Affective Disorders·Yvonne Paelecke-HabermannBernd Leplow
Mar 15, 2006·Neurology·Lambros MessinisPanagiotis Papathanasopoulos
Jun 8, 2006·The Australian and New Zealand Journal of Psychiatry·David SchofieldGail Brennan
Sep 14, 2006·Addiction·Valerie S HarderJeremy Arkes
Mar 17, 2007·The American Journal of Drug and Alcohol Abuse·Vito Agosti, Frances R Levin
Mar 30, 2007·Bipolar Disorders·Noel KennedyPatrick McKeon
Apr 4, 2007·The American Journal of Psychiatry·Pearl H Chiu, Patricia J Deldin
Sep 29, 2009·Clinical Psychology Review·Pim CuijpersGerhard Andersson

❮ Previous
Next ❯

Citations

Jun 12, 2014·The American Journal of Drug and Alcohol Abuse·Patrick V RoebkeFrances R Levin
Apr 14, 2015·The American Journal on Addictions·Deirdre A ConroyMichael D Stein
Feb 28, 2019·Cognitive, Affective & Behavioral Neuroscience·Milena RadomanJodi M Gilman
Jun 1, 2021·Frontiers in Psychiatry·Catherine LangloisSmadar Valérie Tourjman

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Software Mentioned

- MV
MV
CalCAP
- Multimedia
ASI
STARS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.